These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27641564)

  • 21. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
    Glen J; Floros L; Day C; Pryke R;
    BMJ; 2016 Sep; 354():i4428. PubMed ID: 27605111
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.
    Fisher CP; Kierzek AM; Plant NJ; Moore JB
    World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
    Petta S; Valenti L; Bugianesi E; Targher G; Bellentani S; Bonino F; ;
    Dig Liver Dis; 2016 Mar; 48(3):333-42. PubMed ID: 26698409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
    Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paediatric non-alcoholic fatty liver disease: an overview.
    AlKhater SA
    Obes Rev; 2015 May; 16(5):393-405. PubMed ID: 25753407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of fatty liver disease with the metabolic syndrome.
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non alcoholic steatohepatitis (NASH)].
    Coronel M E; Coronel C M
    Rev Gastroenterol Peru; 2016; 36(1):58-65. PubMed ID: 27131942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease and diabetes.
    Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P
    Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of NAFLD: a stage-based approach.
    Rinella ME; Sanyal AJ
    Nat Rev Gastroenterol Hepatol; 2016 Apr; 13(4):196-205. PubMed ID: 26907882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children].
    Li J; Ren WH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):208-212. PubMed ID: 32306653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The benefits of exercise for patients with non-alcoholic fatty liver disease.
    Keating SE; George J; Johnson NA
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age.
    Shen Z; Munker S; Luo F; Ma H; Yu C; Li Y
    PLoS One; 2015; 10(6):e0130614. PubMed ID: 26087253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016.
    Townsend SA; Newsome PN
    Dig Dis; 2017; 35(4):371-376. PubMed ID: 28468015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.